Clene Inc. Common Stock
CLNN Real Time Price USDRecent trades of CLNN by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by CLNN's directors and management
Government lobbying spending instances
-
$10,000 Nov 14, 2024 Issue: Health Issues
-
$50,000 Oct 21, 2024 Issue: Health Issues
-
$150,000 Oct 10, 2024 Issue: Medical/Disease Research/Clinical Labs
-
$10,000 Sep 19, 2024 Issue: Health Issues
-
$50,000 Jul 19, 2024 Issue: Health Issues
-
$100,000 Jul 12, 2024 Issue: Medical/Disease Research/Clinical Labs
-
$10,000 May 02, 2024 Issue: Health Issues
-
$50,000 Apr 22, 2024 Issue: Health Issues
-
$100,000 Apr 07, 2024 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Jul 12, 2023 Issue: Trade (domestic/foreign) Energy/Nuclear
-
$60,000 Apr 20, 2023 Issue: Trade (domestic/foreign) Energy/Nuclear
-
$50,000 Jan 19, 2023 Issue: Trade (domestic/foreign) Energy/Nuclear
-
$50,000 Oct 20, 2022 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Energy/Nuclear
-
$50,000 Jul 18, 2022 Issue: Trade (domestic/foreign) Taxation/Internal Revenue Code Energy/Nuclear
-
$50,000 Apr 20, 2022 Issue: Energy/Nuclear Taxation/Internal Revenue Code Trade (domestic/foreign)
-
$50,000 Jan 19, 2022 Issue: Taxation/Internal Revenue Code Energy/Nuclear Trade (domestic/foreign)
-
$20,000 Oct 21, 2021 Issue: Taxation/Internal Revenue Code Energy/Nuclear Trade (domestic/foreign)
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of CLNN in WallStreetBets Daily Discussion
Recent insights relating to CLNN
Recent picks made for CLNN stock on CNBC
ETFs with the largest estimated holdings in CLNN
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CLNN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.